Southeast AIDS Education and Training Center (SE AETC) | 615-875-7873

Webinar: Outpatient OUD Treatment

Primary Care & Comorbidities, Webcast

Objectives

  • Describe the epidemiology of opioid use and addiction at the national and state levels, highlighting impact of COVID-19
  • Review key principles of addiction medicine including definitions, the brain disease model and SUD diagnostic criteria
  • Discuss three FDA approved treatment options for OUD, with a focus on various buprenorphine formulations.
  • Review important adjunct medications to providing care to individuals with OUD including PrEP, PEP and Naloxone
  • Describe the recent expansion of Tele-BH treatment for OUD

Presentation

Slides

Facilitated by Michael Baca-Atlas, MD, FASAM
Clinical Assistant Professor
UNC Department of Family Medicine
UNC WakeBrook Primary Care
December 2, 2020

Objectives

  • Describe the epidemiology of opioid use and addiction at the national and state levels, highlighting impact of COVID-19
  • Review key principles of addiction medicine including definitions, the brain disease model and SUD diagnostic criteria
  • Discuss three FDA approved treatment options for OUD, with a focus on various buprenorphine formulations.
  • Review important adjunct medications to providing care to individuals with OUD including PrEP, PEP and Naloxone
  • Describe the recent expansion of Tele-BH treatment for OUD

Presentation

Slides

Facilitated by Michael Baca-Atlas, MD, FASAM
Clinical Assistant Professor
UNC Department of Family Medicine
UNC WakeBrook Primary Care
December 2, 2020

Objectives

  • Describe the epidemiology of opioid use and addiction at the national and state levels, highlighting impact of COVID-19
  • Review key principles of addiction medicine including definitions, the brain disease model and SUD diagnostic criteria
  • Discuss three FDA approved treatment options for OUD, with a focus on various buprenorphine formulations.
  • Review important adjunct medications to providing care to individuals with OUD including PrEP, PEP and Naloxone
  • Describe the recent expansion of Tele-BH treatment for OUD

Presentation

Slides